Myc is overexpressed in several types of cancer, which is why studies have been carried out in lung cancer, using CRISPR technology to suppress the expression of this gene by creating Myc knock-out cells, thereby reducing tumor malignancy [38]. This evidence concerns the gene MYC and neoplasm.